glp-1 obesity drugs updates today The Next Phase Of The Drug Race GLP-1 Receptor Agonists Obesity Drugs
Description
The margin over Merck was only $170 million, but the growth gap was far wider: Lilly expanded at 44.7% while Merck managed 1.3%
First, the retrospective design and the reliance on an EHR-based database limited our results
368 Since GLP-1R is expressed in thyroid C cells and GLP-1 directly stimulates the secretion of calcitonin, which is a potent inhibitor of bone resorption in osteoclasts, GLP-1 may contribute to the nutrient-mediated reduction in bone resorption
GLP-1RAs also delay gastric emptying and there are reports that many surgeons recommend discontinuing it temporarily prior to surgery
How does Saxenda cause weight loss
7 , e001112 (2021)
